epigallocatechin gallate has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, N; Wei, R; Yang, W; Zhu, G | 1 |
| Ding, Q; Fang, Z; Gu, B; Xia, G | 1 |
2 other study(ies) available for epigallocatechin gallate and Kidney Neoplasms
| Article | Year |
|---|---|
Epigallocatechin-3-gallate Sensitizes Human 786-O Renal Cell Carcinoma Cells to TRAIL-Induced Apoptosis.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Catechin; Cell Line, Tumor; Cell Survival; Down-Regulation; Flow Cytometry; Humans; Kidney Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; TNF-Related Apoptosis-Inducing Ligand | 2015 |
EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Catechin; Cell Line, Tumor; Flow Cytometry; Gene Expression; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Kidney Neoplasms; Mice; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction | 2009 |